p53 logo

p53

Europe, Rogaland, Norway, Stavanger

Description

p53 identifies and invests in innovative healthcare companies, particularly in the fields of biotechnology and medical devices.

Investor Profile

p53 has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (100%)

Country Focus

  • Norway (50%)
  • Denmark (50%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Life Science
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does p53 frequently co-invest with?

Innovestor
Europe, Southern Finland, Finland, Helsinki
Co-Investments: 1
Forbion Capital Partners
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 1
Industrifonden
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 1
Sarsia
Europe, Hordaland, Norway, Bergen
Co-Investments: 1
Sound Bioventures
Europe, Skane Lan, Sweden, Malmö
Co-Investments: 1
Investinor
Europe, Sor-Trondelag, Norway, Trondheim
Co-Investments: 1
Sunstone Life Science Ventures
Europe, Hovedstaden, Denmark, Copenhagen
Co-Investments: 1

What are some of recent deals done by p53?

Calluna Pharma

Oslo, Oslo, Norway

Calluna Pharma is developing first-in-class therapies designed to defeat chronic inflammation and fibrosis at the source.

BiotechnologyPharmaceutical
Series AJan 23, 2024
Amount Raised: $81,431,633
Teitur Trophics

Aarhus, Midtjylland, Denmark

Teitur Trophics is a biotech company developing novel treatments for neurodegenerative diseases.

BiotechnologyLife ScienceMedical
Series AMar 14, 2023
Amount Raised: $30,034,765